Back

Improving cardiovascular and renal outcomes with Finerenone

22 May 2023 (12:50 - 13:05)
Organised by: Logo
Congress Presentation Part of: Non-steroidal MRAs: protecting the heart and the kidneys Diabetes and the Heart Open Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Christoph Wanner

University Hospital Wuerzburg, Wuerzburg (Germany)

4 More presentations in this session

Presentation thumbnail
Welcome & Introduction
Professor J. Bauersachs (Hannover, DE)
Presentation thumbnail
Unmet needs in the treatment of heart failure
Professor T. McDonagh (London, GB)
Presentation thumbnail
Introducing non-steroidal MRAs in the management of heart failure
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Presentation thumbnail
Discussion & closure

Access the full session

Session thumbnail
Non-steroidal MRAs: protecting the heart and the kidneys

The Event

Event poster

Heart Failure 2023

22 May 2023 12:50 CET
You may be interested in
thumbnail
Congress Session
Finerenone: a disease-modifying therapy for heart and kidney protection
27 August 2023
thumbnail
Congress Presentation
Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage
27 August 2021
thumbnail
Congress Presentation
Finerenone in patients with heart failure and deterioration in eGFR to <25ml/min/1.73m2 in the FINEARTS-HF Trial
17 May 2025
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources